Common Contracts
6 similar Underwriting Agreement contracts by Nuvectra Corp, Beyond Air, Inc., Chembio Diagnostics, Inc., others
2,325,000 Shares Beyond Air, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 12th, 2019 • Beyond Air, Inc. • Surgical & medical instruments & apparatus • New York
Beyond Air, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 2,325,000 shares (the “Firm Shares”) of common stock, $0.0001 par value per share (the “Common Stock”), of the Company. The Firm Shares consist of 2,325,000 authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company has also granted to the several Underwriters an option to purchase up to an aggregate of 348,750 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
Common Stock, par value $0.001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • June 6th, 2019 • OptimizeRx Corp • Services-business services, nec • New York
William Blair & Company, L.L.C. As Representative of the several Underwriters named in Schedule I hereto c/o William Blair & Company, L.L.C. 150 North Riverside Plaza Chicago, Illinois 60606
2,825,000 Shares Nuvectra Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 13th, 2018 • Nuvectra Corp • Surgical & medical instruments & apparatus • New York
Nuvectra Corporation, a Delaware corporation (the “Company”) proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 2,825,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company. The Firm Shares consist of 2,825,000 authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company has also granted to the several Underwriters an option to purchase up to an aggregate of 423,750 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
1,783,760 Shares1 Chembio Diagnostics, Inc. Common Stock, par value $0.01 per share UNDERWRITING AGREEMENTUnderwriting Agreement • February 13th, 2018 • Chembio Diagnostics, Inc. • Pharmaceutical preparations • New York
Chembio Diagnostics, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 1,783,760 shares (the “Firm Shares”) of common stock, par value $0.01 per share (the “Common Stock”), of the Company. The Firm Shares consist of authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company also proposes to grant to the Underwriters an option to purchase up to 0 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
3,248,750 Shares Nuvectra Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2018 • Nuvectra Corp • Surgical & medical instruments & apparatus • New York
Nuvectra Corporation, a Delaware corporation (the “Company”) proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 2,825,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company. The Firm Shares consist of 2,825,000 authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company has also granted to the several Underwriters an option to purchase up to an aggregate of 423,750 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
UNDERWRITING AGREEMENTUnderwriting Agreement • February 18th, 2015 • Ensign Group, Inc • Services-skilled nursing care facilities • New York
